[1]
A. Cuneo and R. Foà, “RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?”, MJHID, vol. 11, no. 1, p. e2019024, Feb. 2019.